List of Excipients in API ATOVAQUONE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ATOVAQUONE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | BENZYL ALCOHOL | |
| GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | POLOXAMER 188 | |
| GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | SACCHARIN SODIUM | |
| GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | WATER | |
| GlaxoSmithKline LLC | MEPRON | atovaquone | 0173-0665 | XANTHAN GUM | |
| GlaxoSmithKline LLC | MALARONE | atovaquone and proguanil hydrochloride | 0173-0675 | CELLULOSE, MICROCRYSTALLINE | |
| GlaxoSmithKline LLC | MALARONE | atovaquone and proguanil hydrochloride | 0173-0675 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ATOVAQUONE
Detailed excipient profiles for ATOVAQUONE
Excipient focus: ALCOHOL
ATOVAQUONE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| VistaPharm LLC | atovaquone | 66689-062 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing ALCOHOL
Excipient focus: BENZYL ALCOHOL
ATOVAQUONE drug variants containing BENZYL ALCOHOL
ATOVAQUONE drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ATOVAQUONE drug variants containing CELLULOSE, MICROCRYSTALLINE
ATOVAQUONE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
ATOVAQUONE drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
| Northstar Rx LLC | atovaquone | 16714-900 |
| Lupin Pharmaceuticals Inc | atovaquone | 68180-282 |
| Glenmark Pharmaceuticals Inc USA | atovaquone | 68462-421 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSPOVIDONE
ATOVAQUONE drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
ATOVAQUONE drug variants containing FERRIC OXIDE RED
ATOVAQUONE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
ATOVAQUONE drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
ATOVAQUONE drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYDROCHLORIC ACID
ATOVAQUONE drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | atovaquone | 51407-642 |
| Bionpharma Inc | atovaquone | 69452-252 |
| A2A Integrated Pharmaceuticals LLC | atovaquone | 73141-104 |
| Kesin Pharma | atovaquone | 81033-104 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
ATOVAQUONE drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
ATOVAQUONE drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Excipient focus: HYPROMELLOSE
ATOVAQUONE drug variants containing HYPROMELLOSE
ATOVAQUONE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
ATOVAQUONE drug variants containing HYPROMELLOSE 2910
ATOVAQUONE drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
ATOVAQUONE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
ATOVAQUONE drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
ATOVAQUONE drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
ATOVAQUONE drug variants containing MAGNESIUM STEARATE
ATOVAQUONE drug variants not containing MAGNESIUM STEARATE
Excipient focus: POLOXAMER 188
ATOVAQUONE drug variants containing POLOXAMER 188
ATOVAQUONE drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ATOVAQUONE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
ATOVAQUONE drug variants containing POLYETHYLENE GLYCOL 400
ATOVAQUONE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
ATOVAQUONE drug variants containing POLYETHYLENE GLYCOL 8000
ATOVAQUONE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POVIDONE
ATOVAQUONE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | atovaquone and proguanil hydrochloride | 0378-4160 |
| Golden State Medical Supply Inc | atovaquone and proguanil hydrochloride | 51407-869 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
ATOVAQUONE drug variants containing POVIDONE K30
ATOVAQUONE drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
ATOVAQUONE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmaceutical Associates Inc | atovaquone | 0121-0888 |
| VistaPharm LLC | atovaquone | 66689-062 |
| Lupin Pharmaceuticals Inc | atovaquone | 68180-282 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
ATOVAQUONE drug variants containing SACCHARIN SODIUM
ATOVAQUONE drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
ATOVAQUONE drug variants containing SILICON DIOXIDE
ATOVAQUONE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
ATOVAQUONE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | atovaquone | 51407-642 |
| Bionpharma Inc | atovaquone | 69452-252 |
| A2A Integrated Pharmaceuticals LLC | atovaquone | 73141-104 |
| Kesin Pharma | atovaquone | 81033-104 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ATOVAQUONE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
ATOVAQUONE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: TITANIUM DIOXIDE
ATOVAQUONE drug variants containing TITANIUM DIOXIDE
ATOVAQUONE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
ATOVAQUONE drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| VistaPharm LLC | atovaquone | 66689-062 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
ATOVAQUONE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | atovaquone | 16714-900 |
| Glenmark Pharmaceuticals Inc USA | atovaquone | 68462-421 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
ATOVAQUONE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | atovaquone | 0121-0956 |
| PAI Holdings LLC | atovaquone | 0121-1016 |
| GlaxoSmithKline LLC | atovaquone | 0173-0665 |
| Major Pharmaceuticals | atovaquone | 0904-7064 |
| KVK-Tech Inc | atovaquone | 10702-223 |
| Northstar Rx LLC | atovaquone | 16714-900 |
| ATLANTIC BIOLOGICALS CORP | atovaquone | 17856-0631 |
| >Company | >Ingredient | >NDC |
ATOVAQUONE drug variants not containing WATER
Excipient focus: XANTHAN GUM
ATOVAQUONE drug variants containing XANTHAN GUM
ATOVAQUONE drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links